Journal of Fungi (Jul 2021)

Severe Posaconazole-Induced Glucocorticoid Deficiency with Concurrent Pseudohyperaldosteronism: An Unfortunate Two-for-One Special

  • Alejandro Villar-Prados,
  • Julia J. Chang,
  • David A. Stevens,
  • Gary K. Schoolnik,
  • Samantha X. Y. Wang

DOI
https://doi.org/10.3390/jof7080620
Journal volume & issue
Vol. 7, no. 8
p. 620

Abstract

Read online

A 56-year-old Hispanic man with a history of disseminated coccidioidomycosis was diagnosed with persistent glucocorticoid insufficiency and pseudohyperaldosteronism secondary to posaconazole toxicity. This case was notable for unexpected laboratory findings of both pseudohyperaldosteronism and severe glucocorticoid deficiency due to posaconazole’s mechanism of action on the adrenal steroid synthesis pathway. Transitioning to fluconazole and starting hydrocortisone resolved the hypokalemia but not his glucocorticoid deficiency. This case highlights the importance of recognizing iatrogenic glucocorticoid deficiency with azole antifungal agents and potential long term sequalae.

Keywords